AGAPE ATP CORPORATION Operating Lease, Expense
AGAPE ATP CORPORATION (ATPC) reported Operating Lease, Expense of $39.83 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-04-01
- AGAPE ATP CORPORATION operating lease, expense for the quarter ending 2023-12-31 was -$104.73K.
- AGAPE ATP CORPORATION operating lease, expense for the quarter ending 2023-09-30 was $45.13K, a 2.36% decline year-over-year.
- AGAPE ATP CORPORATION operating lease, expense for the quarter ending 2023-06-30 was $48.73K, a 10.16% decline year-over-year.
- AGAPE ATP CORPORATION operating lease, expense for the quarter ending 2023-03-31 was $50.71K, a 0.45% increase year-over-year.
- AGAPE ATP CORPORATION operating lease, expense for fiscal 2023 was $39.83K, a 36.61% increase from fiscal 2022.
- AGAPE ATP CORPORATION operating lease, expense for fiscal 2022 was $29.15K, a 83.76% decline from fiscal 2021.
- AGAPE ATP CORPORATION operating lease, expense for fiscal 2021 was $179.56K, a 14.58% increase from fiscal 2020.
- AGAPE ATP CORPORATION operating lease, expense for fiscal 2020 was $156.72K, a 192.41% increase from fiscal 2019.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | -$104.73K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$59.61K derived: sum of 2 quarters · filed 2024-04-01 | -$10.88K derived: sum of 3 quarters · filed 2024-04-01 | $39.83K 10-K · filed 2024-04-01 | |
| 2023-09-30 | $45.13K 10-Q · filed 2023-11-14 | $93.85K derived: sum of 2 quarters · filed 2023-11-14 | $144.56K 10-Q · filed 2023-11-14 | $29.18K derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-06-30 | $48.73K 10-Q · filed 2023-08-14 | $99.43K 10-Q · filed 2023-08-14 | -$15.94K derived: sum of 3 quarters · filed 2024-04-01 | $30.27K derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-03-31 | $50.71K 10-Q · filed 2023-05-15 | -$64.67K derived: sum of 2 quarters · filed 2024-04-01 | -$18.45K derived: sum of 3 quarters · filed 2024-04-01 | $35.78K derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-12-31 | -$115.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$69.16K derived: sum of 2 quarters · filed 2024-04-01 | -$14.92K derived: sum of 3 quarters · filed 2024-04-01 | $29.15K 10-K · filed 2024-04-01 | $190.55K 10-K · filed 2023-03-31 |
| 2022-09-30 | $46.22K 10-Q · filed 2023-11-14 | $100.45K derived: sum of 2 quarters · filed 2023-11-14 | $144.53K 10-Q · filed 2023-11-14 | $194.63K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $54.24K 10-Q · filed 2023-08-14 | $98.31K 10-Q · filed 2023-08-14 | $148.41K derived: sum of 3 quarters · filed 2023-08-14 | $192.76K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $50.48K 10-Q · filed 2023-05-15 | $94.18K derived: sum of 2 quarters · filed 2023-05-15 | $138.52K derived: sum of 3 quarters · filed 2023-05-15 | $184.08K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $43.70K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $88.04K derived: sum of 2 quarters · filed 2023-03-31 | $133.60K derived: sum of 3 quarters · filed 2023-03-31 | $179.56K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $44.34K 10-Q · filed 2022-11-14 | $89.90K derived: sum of 2 quarters · filed 2022-11-14 | $135.87K 10-Q · filed 2022-11-14 | $181.12K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $45.56K 10-Q · filed 2022-08-11 | $91.52K 10-Q · filed 2022-08-11 | $136.77K derived: sum of 3 quarters · filed 2022-08-11 | $195.56K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $45.96K 10-Q · filed 2022-05-13 | $91.21K derived: sum of 2 quarters · filed 2022-07-05 | $150.00K derived: sum of 3 quarters · filed 2022-07-05 | $202.68K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-12-31 | $45.25K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $104.04K derived: sum of 2 quarters · filed 2022-07-05 | $156.72K derived: sum of 3 quarters · filed 2022-07-05 | $156.72K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $58.79K 10-Q/A · filed 2022-07-05 | $111.47K derived: sum of 2 quarters · filed 2022-07-05 | $111.47K 10-Q/A · filed 2022-07-05 | $138.40K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-06-30 | $52.67K 10-Q · filed 2021-08-13 | $66.18K 10-Q · filed 2021-08-13 | $79.61K derived: sum of 3 quarters · filed 2021-08-13 | $93.01K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $13.51K 10-Q · filed 2021-05-17 | $26.94K derived: sum of 2 quarters · filed 2021-05-17 | $40.34K derived: sum of 3 quarters · filed 2021-05-17 | $53.73K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $13.43K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | $26.83K 10-K · filed 2021-03-31 | $40.22K derived: sum of 3 quarters · filed 2021-03-31 | $53.59K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $13.40K 10-Q · filed 2020-11-16 | $26.79K derived: sum of 2 quarters · filed 2020-11-16 | $40.17K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $13.39K 10-Q · filed 2020-08-13 | $26.77K 10-Q · filed 2020-08-13 | $35.71K 10-K · filed 2020-03-27 | ||
| 2019-03-31 | $13.38K 10-Q · filed 2020-05-14 | ||||
| 2018-12-31 | $8.93K 10-K · filed 2020-03-27 | ||||
| 2018-06-30 | $0.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |